2010
Annual Progress Report Brochure
[scribd id=48043042 key=key-2lsqkzwb7pj0xqcvmrs8 mode=slideshow]
2009
Annual Progress Report Brochure
[scribd id=47484405 key=key-2iltgygj58flji4g53fy mode=slideshow]
2008
Annual Progress Report Brochure
[scribd id=47484303 key=key-510kkxzey12awgj0a9m mode=slideshow]
Biozona is the brand identity for Arizona’s growing bioscience sector. The Biozona name, symbol, and tagline—”Advancing Science. Enhancing Life.”—promote Arizona as a place where science thrives for the benefit of all.
Arizona has internationally competitive assets in the biosciences and, through its collaborative, statewide plan, Arizona is growing its bioscience base more quickly than perhaps any other state. Yet, the state previously lacked a prominent identity in the biosciences. This is essential to strengthen in-state education and awareness efforts, market to out-of-state audiences, and present the collaborative strengths of statewide institutions and programs.
Arizona’s Bioscience Roadmap recommended in 2002 that the state needed to develop a creative identity for its bioscience sector. This recommendation has been repeated by numerous statewide bioscience leaders since then.
Biozona is the result of a collaborative effort by a network of communications and marketing officials from more than 35 organizations integrally involved in the biosciences in Arizona. Efforts were coordinated with the Governor’s Council on Innovation and Technology to ensure cohesiveness with the council’s current plans for branding Arizona’s high-tech sector. Initial efforts to develop a bioscience identity were undertaken by a collaborative group, led by Governor’s office, in 2004.
The developers of the logo encourage its use to represent collaborative efforts by statewide organizations involved in the biosciences. Examples: collateral material, PowerPoint presentations, fact sheets, Web sites, trade-show banners, promotional items, and advertisements. Individual institutions are encouraged to display the logo on presentation materials to illustrate their participation in a greater whole.
The original content on this page was compiled and contributed by the Flinn Foundation
“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease and Save Lives” Provides Roadmap for Transformative Policy Changes
WASHINGTON, D.C. (Wednesday, June 29, 2011) – The Biotechnology Industry Organization (BIO) released today a summary of legislative proposals to reform the investment and regulatory environment for biotech innovation. These proposals are designed to unleash the innovation required to cure disease and make the U.S. healthcare system more affordable, efficient, and of higher quality, as well as to foster the development of breakthrough technologies to provide alternative energy sources, combat hunger and protect against bio-terrorism. The policy proposals, released at a press briefing at the 2011 BIO International Convention held here this week, will serve as the organization’s targeted advocacy plan in these two areas.
Biosphere 2 to Have a Permanent Home With the UA
New salmonella-based ‘clean vaccines’ aid the fight against infectious disease (ASUBiodesign)
International Genomics Consortium contributes to The Cancer Genome Atlas’ detailed ovarian cancer analysis Findings point to new means of assessing patient survival
Institute for Advanced Health Chooses Phoenix ~ Dr. Patrick Soon-Siong’s vision takes root in Phoenix.
LaBaer named Health Care Heroes finalist for discoveries in breast cancer detection and treatment. (ASUBiodesign)
Improving Health Care with Better Information – Tuscon Medical Center (TMC) leverages tech to improve patient care.
Arizona Board of Regents approves new Cancer Center in Downtown Phoenix
Looking Back and Looking Forward: A great video and a great legacy. Thank you President Shelton for your commitment to leadership and to our AZBio community.
Ventana’s Phil Miller recognized for improving the lives of millions of cancer
patients.
Regenesis Biomedical Announces $5.3 Million in Series C Funding
Phoenix Children’s Hospital debuts expanded campus (Business Journal)
There has been a lot of talk about budgets and debt ceilings in Washington this week. The negotiations – now taking place between the President and Congressional leaders are fluid, closely held, and difficult to predict. It does not take a PhD to know that Medicare and Medicaid cuts are on the table.
At AZBIO we stay in close communication with our partners at BIO, PhRMA, and AdvaMed so that we can share the latest news with our members.Continue reading
Press Release from BIO: The Leahy-Smith America Invents Act will benefit all sectors of U.S. economy
Washington, D.C. (June 23, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage of The Leahy-Smith America Invents Act, H.R. 1249, by the House of Representatives:
“Small biotechnology companies rely heavily on their patents to attract investment to fund the lengthy and expensive research and development process necessary to bring breakthrough medical therapies and other products to patients and consumers. Strong intellectual property protection is critical for these companies.
“The Leahy-Smith America Invents Act will bring our patent system into the 21st century. The improvements made by the bill will benefit all sectors of the national economy by enhancing patent quality and the efficiency, objectivity, predictability and transparency of the U.S. patent system.
Innovative medical technology companies in all stages of development are eligible to apply to make a 9-minute business development presentation during AdvaMed 2011: The MedTech Conference. The conference will take place in Washington D.C., at the Walter E. Washington Convention Center, September 26-28, and the deadline to apply to present to strategic partners, venture capital firms and angel investors is July 11.Continue reading
It’s hard to grow without the right resources. It takes more than a great idea and passion. You need the right team, access to partners access marketing and manufacturing resources and so much more and that takes capital. But accessing the right money is one of the most challenging tasks any entrepreneur will tackle.
Invest Southwest and the Venture Capital Conference in the Rockies (VCIR) are partnering together to form the premier capital conference in the Southwest. This year’s event connects the region’s most promising startups and emerging growth companies with an audience of hundreds of venture investors, entrepreneurs and service professionals. Investors and venture capitalists from all over the globe will gather to see the “Best of the Southwest” present their business plans and investment opportunities. Presenting companies of Invest Southwest have received more than a quarter billion in investment dollars since the inception in 1992 and companies that have presented at VCIR over the past 10 years have collectively generated nearly $5 billion in exit value for their stakeholders.
In November, investors and venture capitalists from across the country will gather at the J.W. Marriott Desert Ridge Resort and Spa in Phoenix to see the “Best of the Southwest” present their business plans and investment opportunities.Continue reading
During his 5-year tenure leading at the University of Arizona, President Robert Shelton created both an impressive tenure and laid the foundation for a lasting legacy. Shelton will depart the UA at the end of next month, having served five years as the institution’s 19th president. He will become executive director of the Fiesta Bowl, beginning August 1, 2011. Read more here.
Thank you President Shelton for your commitment to the U of A, to our bioscience community and to our state.Continue reading
When it comes to moving things forward…faster a personal touch is always a key ingredient. Last week at AZBio we saw many examples of that as our team, our leadership, our strategic partners and our members all came together to work on key projects. Continue reading